| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 5, 2026 | ±2.9% | +0.9% | over-priced |
| October 28, 2025 | ±4.5% | -0.7% | over-priced |
| July 29, 2025 | ±3.5% | -1.2% | over-priced |
| April 29, 2025 | ±3.5% | +0.9% | over-priced |
| October 29, 2024 | ±3.1% | -0.4% | over-priced |
| July 30, 2024 | ±3.5% | +1.4% | over-priced |
| April 30, 2024 | ±2.8% | -0.5% | over-priced |
| October 31, 2023 | ±3.0% | +0.8% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $2.18 | $2.3B | $168M |
| Q4 FY2025 | $2.15 | $2.3B | $166M |
| Q3 FY2025 | $2.13 | $2.2B | $166M |
| Q2 FY2025 | $2.41 | $2.2B | $189M |
Avery Dennison Corp. (AVY) reports in 99 days, with the next report estimated for September 20, 2026. Across the last 8 reports, options priced an average ±3.3% earnings move while the stock actually moved 0.8% on average — the market has systematically over-priced AVY's earnings risk. Fundamentals into the print: EPS up 4.3% year-over-year, revenue up 7.0%. QuantLogix's live 5-factor engine currently reads AVY as a buy at 51/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →